Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma models.

Morita, Satoru; Kikuchi, Hiroto; Birch, Grace; Matsui, Aya; Morita, Atsuyo; Kobayashi, Tatsuya; Ruan, Zhiping; Huang, Peigen; Hernandez, Alexei; Coyne, Erin M; Shin, Sarah M; Yarchoan, Mark; Mino-Kenudson, Mari; Romee, Rizwan; Ho, Won Jin; Duda, Dan G

Morita, Satoru; Kikuchi, Hiroto; Birch, Grace; Matsui, Aya; Morita, Atsuyo; Kobayashi, Tatsuya; Ruan, Zhiping; Huang, Peigen; Hernandez, Alexei; Coyne, Erin M; Shin, Sarah M; Yarchoan, Mark; Mino-Kenudson, Mari; Romee, Rizwan; Ho, Won Jin; Duda, Dan G.

bioRxiv ; 2023 Oct 23.

Article in En | MEDLINE | ID: mdl-37961529

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634718
https://dx.doi.org/10.1101/2023.10.20.563378

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article Country of publication: United States

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634718
https://dx.doi.org/10.1101/2023.10.20.563378

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article Country of publication: United States